NRC · Nasdaq · CIK 0000070487
NRC HEALTH
NRC HEALTH’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 27, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $137.4M and net income of $11.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 13 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- NRC HEALTH
- Ticker
- NRC
- SEC Central Index Key (CIK)
- 0000070487
- Industry (SIC)
- Services-Commercial Physical & Biological Research (code 8731)
- Business address
- LINCOLN, NE
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Accelerated filer
- Position in SEC ticker list
- #2949 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from NRC HEALTH’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Net income | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| Diluted EPS | $1.46 | $1.27 | $1.25 | $1.04 | $50.00 |
| Total assets | $157.5M | $130.5M | $122.4M | $132.5M | $134.9M |
| Cash and equivalents | $54.4M | $25.0M | $6.7M | $4.2M | $4.1M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Mar 5, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 4, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Oct 27, 2026 | 8-K | Results of operations· period Oct 27, 2026 | Document · Index |
| May 8, 2026 | DEF 14A | Definitive proxy statement· period Jun 23, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about NRC HEALTH, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 27, 2026 | 8-K | Results of operations· period Oct 27, 2026 | Document · Index |
| Oct 19, 2026 | 8-K | Director or officer change· period Oct 14, 2026 | Document · Index |
| Aug 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 11, 2026 | 8-K | Director or officer change· period Aug 7, 2026 | Document · Index |
| Aug 4, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Jul 28, 2026 | 8-K | Results of operations· period Jul 28, 2026 | Document · Index |
| Jun 29, 2026 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results· period Jun 23, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 12, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| May 13, 2026 | 424B7 | 424B7 | Document · Index |
| May 8, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| May 8, 2026 | DEF 14A | Definitive proxy statement· period Jun 23, 2026 | Document · Index |
| May 8, 2026 | ARS | ARS· period Dec 31, 2025 | Document · Index |
| May 6, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| Apr 28, 2026 | PRE 14A | PRE 14A· period Jun 23, 2026 | Document · Index |
| Apr 28, 2026 | 10-K/A | Amended annual report· period Dec 31, 2025 | Document · Index |
| Apr 28, 2026 | 8-K | Director or officer change· period Apr 27, 2026 | Document · Index |
| Apr 28, 2026 | 8-K | Results of operations· period Apr 28, 2026 | Document · Index |
| Apr 20, 2026 | 8-K | Director or officer change; Charter, bylaws or fiscal year change· period Apr 15, 2026 | Document · Index |
| Mar 27, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Mar 13, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Mar 12, 2026 | Document · Index |
| Mar 5, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| Mar 5, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Mar 5, 2026 | 8-K | Regulation FD disclosure· period Mar 4, 2026 | Document · Index |
| Feb 19, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Feb 17, 2026 | Document · Index |
| Feb 17, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026 | Document · Index |
| Feb 17, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026 | Document · Index |
| Feb 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 10, 2026 | 424B7 | 424B7 | Document · Index |
| Feb 3, 2026 | 8-K | Results of operations· period Feb 3, 2026 | Document · Index |
| Jan 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 29, 2025 | Document · Index |
| Jan 16, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 5, 2026 | Document · Index |
| Jan 16, 2026 | 3 | Initial statement of beneficial ownership· period Jan 5, 2026 | Document · Index |
| Jan 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jan 5, 2026 | Document · Index |
| Dec 17, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 15, 2025 | Document · Index |
| Nov 7, 2025 | 10-Q | Quarterly report· period Sep 30, 2025 | Document · Index |
Insider filing activity
13 Form 4 filings appear in NRC HEALTH’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Services-Commercial Physical & Biological Research
- IQV IQVIA HOLDINGS INC.
- INCY INCYTE CORP
- MEDP Medpace Holdings, Inc.
- CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- ICLR ICON PLC
- ABSI Absci Corp
- OABI OmniAb, Inc.
All 8 companies in Services-Commercial Physical & Biological Research· Companies headquartered in Nebraska
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000070487 and XBRL company facts. NRC HEALTH on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement